dc.contributor
Institut Català de la Salut
dc.contributor
[Ciudin A] Servei d’Endocrinologia i Nutrició, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Departament de Fisiologia Humana i Immunologia, Universitat Autònoma de Barcelona, Bellaterra, Spain. CIBER de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDem), Instituto de Salud Carlos III, Madrid, Spain. [Simó R] Servei d’Endocrinologia i Nutrició, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. CIBER de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDem), Instituto de Salud Carlos III, Madrid, Spain. Departament de Medicina, Universitat Autònoma de Barcelona, Bellaterra, Spain
dc.contributor
Vall d'Hebron Barcelona Hospital Campus
dc.contributor.author
Simó Canonge, Rafael
dc.contributor.author
Ciudin Mihai, Andreea
dc.date.accessioned
2023-11-08T15:25:28Z
dc.date.available
2023-11-08T15:25:28Z
dc.date.issued
2023-01-09T12:29:13Z
dc.date.issued
2023-01-09T12:29:13Z
dc.date.issued
2022-12-01
dc.identifier
Ciudin A, Simó R. New methods for the diagnosis and monitoring of cognitive function in patients with type 2 diabetes. Front Endocrinol. 2022 Dec 1;13:1024794.
dc.identifier
https://hdl.handle.net/11351/8757
dc.identifier
10.3389/fendo.2022.1024794
dc.identifier.uri
https://hdl.handle.net/11351/8757
dc.description.abstract
Dementia; Retinal microperimetry; Type 2 diabetes
dc.description.abstract
Demencia; Microperimetría retiniana; Diabetes tipo 2
dc.description.abstract
Demència; Microperimetria retiniana; Diabetis tipus 2
dc.description.abstract
The presence of type 2 diabetes acts as an accelerator of cognitive impairment (mild cognitive impairment and later dementia), with a significant impact on the management of the disease and its complications. Therefore, it is recommended to perform an annual evaluation of cognitive function in patients with diabetes older than 65 years. Current guidelines still recommend the use of the Minimental State Evaluation Test (MMSE) as screening test, but it has a modest sensitivity and specificity for identifying mild cognitive impairment. This represents an important gap because patients with mild cognitive impairment are at risk of progressing to dementia. The neurocognitive diagnosis is based on complex neuropsychological tests, which require specifically trained personnel and are time consuming, making its routine incorporation into daily clinical practice unfeasible. Therefore, at present there are no reliable biomarkers to identify patients with type 2 diabetes at increased risk of developing cognitive impairment. Since the brain and the retina have a common embryological origin, our Research Group, has worked over the last 10 years evaluating the usefulness of the retina as a “window” to the brain. We provided evidence that retinal microperimetry is a simple, feasible and useful tool for screening and monitoring cognitive function in patients with type 2 diabetes. We propose a review of actual tests recommended for screening of cognitive impairment as well as an update of new emerging methods, such as retinal microperimetry.
dc.format
application/pdf
dc.publisher
Frontiers Media
dc.relation
Frontiers in Endocrinology;13
dc.relation
https://doi.org/10.3389/fendo.2022.1024794
dc.rights
Attribution 4.0 International
dc.rights
http://creativecommons.org/licenses/by/4.0/
dc.rights
info:eu-repo/semantics/openAccess
dc.subject
Diabetis no-insulinodependent - Complicacions
dc.subject
Trastorns de la cognició - Diagnòstic
dc.subject
Tests neuropsicològics
dc.subject
DISEASES::Endocrine System Diseases::Diabetes Mellitus::Diabetes Mellitus, Type 2
dc.subject
Other subheadings::Other subheadings::Other subheadings::/complications
dc.subject
PSYCHIATRY AND PSYCHOLOGY::Mental Disorders::Neurocognitive Disorders::Cognition Disorders::Cognitive Dysfunction
dc.subject
Other subheadings::Other subheadings::/diagnosis
dc.subject
PSYCHIATRY AND PSYCHOLOGY::Behavioral Disciplines and Activities::Psychological Tests::Neuropsychological Tests
dc.subject
ENFERMEDADES::enfermedades del sistema endocrino::diabetes mellitus::diabetes mellitus tipo II
dc.subject
Otros calificadores::Otros calificadores::Otros calificadores::/complicaciones
dc.subject
PSIQUIATRÍA Y PSICOLOGÍA::trastornos mentales::trastornos neurocognitivos::trastornos cognitivos::disfunción cognitiva
dc.subject
Otros calificadores::Otros calificadores::/diagnóstico
dc.subject
PSIQUIATRÍA Y PSICOLOGÍA::disciplinas y actividades conductuales::pruebas psicológicas::pruebas neuropsicológicas
dc.title
New methods for the diagnosis and monitoring of cognitive function in patients with type 2 diabetes
dc.type
info:eu-repo/semantics/article
dc.type
info:eu-repo/semantics/publishedVersion
